CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome

Penn State Hershey Medical Center, Hershey

Virginia Clinical Research, Inc., Norfolk

Duke University, Durham

Gwinett Clinical Research Center, Snellville

Park Avenue Dermatology, Orange Park

Ameriderm Research, Ormond Beach

Clinical Coordinating Center (Minnesota), New Brighton

Mayo Clinic - Minnesota, Rochester

St. Louis University, St Louis

Burke Pharmaceuticals Research, Hot Springs

DermResearch Inc, Austin

University of Utah, Murray

Mayo Clinic, Scottsdale

Stanford Univeristy, Palo Alto

St. Pancras Clinical Research, London

Salford Foundation Trust, Salford